Sandip M. Prasad, MD

Sandip M. Prasad, MD, discusses future directions for investigating mitomycin intravesical solution in the ENVISION trial for NMIBC.

Sandip M. Prasad, MD, details key findings from a post hoc analysis of CR rates and DOR in the phase 3 ENVISION trial.

Sandip M. Prasad, MD, discusses prior data from the phase 3 ENVISION trial in NMIBC.